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Abstract
The direct fluorescent antibody test (DFA), is performed in all rabies reference laboratories
across Latin America and the Caribbean (LAC). Despite DFA being a critical capacity in the
control of rabies, there is not a standardized protocol in the region. We describe the results
of the first inter-laboratory proficiency exercise of national rabies laboratories in LAC coun-
tries as part of the regional efforts towards dog-maintained rabies elimination in the Ameri-
can region. Twenty three laboratories affiliated to the Ministries of Health and Ministries of
Agriculture participated in this exercise. In addition, the laboratories completed an online
questionnaire to assess laboratory practices. Answers to the online questionnaire indicated
large variability in the laboratories throughput, equipment used, protocols availability, quality
control standards and biosafety requirements. Our results will inform actions to improve
and harmonize laboratory rabies capacities across LAC in support for the regional efforts
towards elimination of dog-maintained rabies.
Author summary
The incidence of dog-maintained rabies in Latin America has showed a significant reduc-
tion in the last 30 years. Although several countries have achieved its elimination there are
still focalized areas in the region where rabies remain endemic. Many factors, including
poverty, geographic and environmental features, as well as social, cultural, political and
economic variables, have limited the effective implementation of canine rabies control
programs in these endemic areas. Critical to the goal of control and elimination of rabies
is a robust laboratory diagnostic capacity. This report presents the results of an Inter-labo-
ratory proficiency testing exercise for rabies diagnosis by direct fluorescent antibody test
among laboratories across Latin America and the Caribbean (LAC). Our results indicate
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that although all laboratories can perform the direct fluorescent antibody test, there are
substantial differences in the overall results and test interpretation. This study identified
important gaps in standardization and/or harmonization between laboratories which
could be overcome and corrected with appropriate DFA protocols standardized across the
LAC, including its broad distribution and proper training.
Introduction
Conclusive rabies diagnosis can only be achieved by appropriate laboratory testing. Clinical
and epidemiological diagnosis is challenging and leads to under-reporting [1, 2, 3]. The Direct
Fluorescent Antibody test (DFA) for detection of rabies virus antigen remains as the gold stan-
dard test for laboratory diagnosis of rabies in post-mortem brain tissues [3].
In addition to its essential role in the confirmation of clinical rabies, laboratory diagnosis
supports rabies surveillance and the clinical management of patients exposed to a potentially
rabid animal. In the case of disease surveillance in rabies endemic countries, laboratory diag-
nosis of suspected rabid animals is important for assessing the distribution and prevalence of
the disease in its major reservoir hosts. In the case of human exposures to potentially rabid ani-
mals, the decision to administer post-exposure prophylaxis (PEP) depends on the results of
observation and/or laboratory testing of the animal involved [2]. Laboratory diagnosis can
avert the financial losses incurred by the unnecessary application of PEP in the case of negative
results, and trigger adequate human case patient management and adequate occupational
health risk assessments in the case of positive results [4, 5].
Due to a concerted elimination effort by the Latin America and Caribbean (LAC) countries,
cases of human rabies transmitted by dogs have been reduced to a small number in well-
defined areas in the region [6, 7]. As part of the regional strategies towards dog-associated
rabies elimination, it is necessary to standardize rabies diagnostic testing across LAC to
improve quality, enhance laboratory diagnostic capability and allow multinational inter-labo-
ratory comparisons and analyses of regional surveillance data [8, 9]. To address this need, the
Action Plan for the Elimination of Dog-Transmitted Rabies in LAC [6] seeks the implementa-
tion of an Inter-American Network of Rabies Diagnostic Laboratories (REDILAR- from the
Spanish acronym, Red Interamericana de Laboratorios de Diagnostico de Rabia) to facilitate
rapid and reliable diagnosis, promote regional training opportunities and develop a regional
laboratory quality assurance program. To this effect, and following recommendations from
the 14th Regional Meeting of National Rabies Program Managers, (REDIPRA 14 from the
Spanish acronym) [10] a proficiency testing exercise was carried out within the LAC countries.
This report describes an Inter-laboratory proficiency testing (IPT) exercise for rabies diagnosis
by DFA, and a baseline assessment of laboratory practices and infrastructure among rabies
diagnostic laboratories in LAC. Specifically, the objectives of this IPT were to assess the diag-
nostic capacity of each laboratory to perform the DFA test and identify specific laboratory
needs for training and equipment. In regards the assessment laboratory practices, the objective
was to identify differences in the laboratory protocols that could explain discrepant laboratory
results and provide baseline knowledge for regional standardization of protocols.
Materials and methods
Participating laboratories
Thirty national or regional (as in regions or states within the countries) rabies reference labo-
ratories, affiliated with the ministries of health (MoH) and/or agriculture (MoAg) agreed to
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participate in the exercise in response to an invitation from the Pan American Foot-and-
Mouth Disease Center (PANAFTOSA in Spanish) of the Pan American Health Organization
(PAHO) located in Rio de Janeiro, Brazil. By targeting MoH and MoAg affiliated laboratories,
the exercise aimed to comprehensively capture rabies diagnosis practices, on human and ani-
mal samples. Across LAC countries, MoH laboratories mostly perform diagnosis on human
and domestic animals samples, whereas MoAg laboratories focus on livestock and wildlife sub-
missions. Participation in the IPT exercise and baseline operations assessment was voluntary.
Thirteen laboratories were affiliated with the MoH and seventeen with the MoAg. The 30
participating laboratories were located in the following countries: Argentina (MOH/MoAg),
Bolivia (MOH/MoAg), Brazil (MOH/MoAg), Canada (MoAg), Chile (MOH), Colombia
(MOH/MoAg), Costa Rica (MoAg), Cuba (MoAg), Ecuador (MoAg), Dominican Republic
(MoAg), El Salvador (MoAg), Guatemala (MOH/MoAg), Haiti (MoAg), Honduras (MoAg),
Mexico (MOH/MoAg), Nicaragua (MOH), Panama (MoAg), Paraguay (MOH/MoAg), Peru
(MOH), Trinidad and Tobago (MoAg) and Uruguay(MoAg). The laboratories were randomly
coded as L1 to L30.
Source of panel material and panel composition
Brain tissue impression slides used in the exercise were prepared at the Poxvirus and Rabies
Branch of the US Centers for Disease Control and Prevention (CDC) and represented samples
received for routine rabies diagnosis or typing with variations in antigen load and distribution.
All tissues were obtained from naturally occurring rabies cases in major host reservoir species
without passage in a secondary susceptible animal. No animals were used or harmed in any
way for this study.
Each PT panel constituted by 20 samples included 17 test samples and 3 controls. Positive
tissues contained major rabies virus variants circulating in the Americas. Negative samples,
encompassed tissues demonstrating complete absence of rabies virus antigen and artifacts, and
some with atypical golden lipofuscin and atypical nonspecific fluorescent bacteria or fluores-
cent artifacts. Lipofuscin within CNS tissues is commonly detected in cerebellum of cats and
brain tissues from older animals, and appears as golden "pseudo-inclusions" with diffuse out-
line when DFA slides are observed with FITC filters exciting in blue light wavelengths. The
lipofuscin will be observed in tissues which are stained by immunofluorescence as well as in
tissues without conjugate applied. Often inexperienced individuals reading slides, particularly
those working with conjugates at less than optimal dilution or deficient microscope equip-
ment, may not be able to observe rabies positive virus antigen as sparkling 4+ apple-green fluo-
rescence, which in turn prevents distinguishing artifacts.
The samples with lipofuscin were purposely chosen among CDC archived samples to dem-
onstrate the golden atypical objects easily distinguished by competent laboratorians.
Details of the rabies virus variants included in the IPT panel are listed in Table 1 by both
predominant host reservoir species, and antigenic type as indicated by the use of a panel of
eight monoclonal antibodies (Mabs) directed to the rabies virus N protein [11].
All rabies positive brain tissues were inactivated via gamma-irradiation with 5 x 106 rads
using a Gamma Cell Irradiator (Gammacell 220 Excel, MDS Nordion, Canada) to exclude any
infectious agent in order to facilitate safe importation procedures. To confirm complete inacti-
vation of rabies virus, isolation was attempted in mouse neuroblastoma (MNA) cell culture.
Brain homogenates (10% w/v) were prepared in Magna NA Lyser tissue homogenizer tubes
containing 1.4-mm (diameter) ceramic beads (Roche Applied Science, Penzberg, Germany),
using 1.0 mL of MEM-10 as a diluent. For virus recovery, 100μL of test inoculum was added to
1mL of MEM-10 containing 5x106 mouse neuroblastoma cells (MNA) in a T-25 tissue culture
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flask (Corning, NY). Tissue culture flasks were incubated at 0.5% CO2 at 37˚C for 72 hours
prior to passaging. All cultures were sub-passaged a minimum of three times. For infectivity
assessments, Teflon-coated four well slides were seeded with 30uL of MEM-10 containing 0.5
x 106 cells per mL, and incubated in a humid chamber at 0.5% CO2 at 37˚C for 24 hours. The
slides were then rinsed with phosphate-buffered saline (PBS), and fixed in cold acetone at
-20˚C for one hour. Cells were checked for the presence of RABV antigens by the DFA test,
using optimal working dilutions of FITC-labeled anti-RABV mAb conjugate (Fujirebio Diag-
nostics, Inc., Malvern, PA, USA) after each passage. This testing method was performed in
duplicate by multiple, qualified testing personnel at the CDC in Atlanta, Georgia.
After tissue inactivation and safety testing procedures concluded, tissues were re-tested by
DFA to confirm antigen was not damaged. From all selected inactivated tissues, a total of 600
touch impression slides were prepared according to the standard protocol for the postmortem
diagnosis of rabies by the DFA test [12]. All slides were acetone fixed at -20˚C overnight and
stored at -80˚C until packaging and shipment from CDC to PANAFTOSA. After the panels
arrived to PANAFTOSA in Brazil, the material was distributed to all the participating laborato-
ries. Each shipment contained a document with instructions, and the results reporting sheet.
Table 1. Rabies panel composition and rabies virus variants used in this study.






(Dog Variant) Not Passaged Canis lupus familiaris Naturally infected animal 4+/4+
2 Weak Positive
Control
3 Not Passaged Bos taurus Naturally infected 4+/2+
3 Negative Control N/A N/A Negative healthy (Sheep) Non-rabid animal 0/0
4 PT 1 1 (Dog Variant) Not Passaged Canis lupus familiaris Brain stem or cerebellum 4+/3-4+




6 PT 3 7 (AZ Gray Fox) Not passaged Urocyon cinereoargenteus Brain stem or cerebellum 4+/2-3+
7 PT 4 Negative Dog N/A Canis lupus familiaris Very clear negative 0/0
8 PT 5 3 (Vampire) Bovine Bos taurus Brain stem or Cerebellum 4+/2+
9 PT 6 4 (Tadarida
brasiliensis)
Not Passaged Tadarida brasiliensis Brain from naturally infected 4+/3+
10 PT 7 (Negative) N/A fox Infected with Listeria
monocytogenes
brain tissue containing bacteria Non-specific staining
11 PT 8 Negative skunk NA Mephitis mephitis DFA Negative sample 0/0
12 PT 9 South Central US
North Central MX
Not Passaged Mephitis mephitis Brain stem or Cerebellum 4+/2+
13 PT 10 6 (Lasiurus
cinereus)
Fox Lasiurus cinereus Brain from naturally infected 4+/4+
14 PT 11 Negative Non-rabid Molossus molossus Non rabid animal 0/0
15 PT 12 Western Eptesicus
fuscus
Not passaged Eptesicus fuscus Brain from naturally infected 4+/3-4+
16 PT 13 Negative Non-rabid Ursus arctos Brain stem or cerebellum 0/0 Golden
autofluorescence
17 PT 14 Negative Non-rabid Sus domesticus Brain stem or cerebellum Non-specific staining
18 PT 15 Negative Non-rabid mouse Sample infected with group G
streptococcus
0/0
19 PT 16 Mongoose
(PuertoRico)
Not passaged Herpestes javanicus Brain stem or cerebellum 4+/4+
20 PT 17 Negative Non-passaged Sheep Brain stem or Cerebellum 0/0 Negative
https://doi.org/10.1371/journal.pntd.0005427.t001
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The shipping time from dispatch to receipt by the laboratories was recorded. Laboratories
were requested to submit the reporting sheet within two months of receipt of the samples.
Panel testing
The slides were designed to cover different situations faced during routine testing in the par-
ticipating laboratories. The participants were asked to test the samples using the standard pro-
tocol in their laboratory, record their results (positivity, intensity, and distribution of the
fluorescence staining) in the reporting sheet, and the microscopic condition and impression
quality of the tissues (Good, Acceptable, or Deficient) as evaluated by the laboratory operator.
The microscopic condition refers to the integrity of the cells facilitating fluorescence interpre-
tation (cytoplasmic or nuclear) under the microscope and the tissue impression quality refers
to how well the tissue impressions were made and if there was sufficient material (tissue) to
read the slide and reach a diagnosis as assessed by an overall visual inspection.
In addition, for the laboratory practices assessment, a questionnaire to study the variability
of diagnostic techniques, available resources, quality control, and safety procedures was sent
electronically to the participating laboratories in parallel to the panel
Data synthesis and analysis
The sensitivity, specificity, and Cohen’s kappa coefficient to measure the inter-rater agreement
values were calculated for each laboratory. Samples for which no result was returned were con-
sidered missing and were not included in the analysis. Inconclusive samples (as classified by
the laboratory on the reporting sheet) were excluded from the sensitivity and specificity calcu-
lations, but were considered for the kappa and concordance calculations. The level of concor-
dance was calculated by laboratory and by sample as the number of results in agreement with
those of the CDC over the total number of results; inconclusive results were included in the
denominator.
Exploratory data analyses were carried out to investigate the relationship between the labo-
ratories concordance results and laboratory practices as captured by the laboratory practices
assessment. One-way ANOVA and Mann-Whitney U tests, the latter if the distributional
assumptions underlying the parametric test were not satisfied, were used to compare groups of
respondents to the questionnaire. An alpha of< 0.05 was considered statistically significant.
The overall microscopic condition and impression quality of the tissues for each laboratory
panel and for each of the samples across the laboratories was calculated as the percent samples
reported as deficient. In the case of two samples for which the operators from the same labora-
tory evaluated the quality of a slide differently (i.e. Good/Deficient or Adequate/Deficient), the
quality was coded as Deficient for the purposes of the analysis. The data analysis was per-
formed in R (i386 3.1.2) [13].
Quality control verification
To assess potential shipping problems during transportation of PT panels to all participating
laboratories, the stability of rabies antigen and reproducibility of the DFA test results was
determined a priori. Two complete panel sets were maintained under 5 different temperatures
(-80˚C, -20˚C and 4˚C, room temperature and 37˚C) as well as 3 different storage time (3, 7
and 14 days) to mimic potential transport and storage conditions. Thus, a great total of 600
slides with two tissue impressions were tested for all combinations of these conditions. At all
time points and storage conditions one complete panel set was run using FDI Fujirebio Diag-
nostics Inc. cat# 800–092 and the other with EMD Millipore Light Diagnostics cat#5100). A
control conjugate EMD Millipore Cat#5102 was used (non-rabies FITC labeled antibody of
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the same isotype as the FITC labelled monoclonal) to assess the specificity of the reaction. Both
the fluorescent intensity and the antigen distribution were reported for each case. A total of 36
test results were reported and analyzed for each of the 20 samples in each panel tested. The
result of this testing was compared against the baseline value provided by the CDC which was
the result of samples stored at -80˚C. There were sufficient sample slides for all planned storage
variations except sample# 12 (WEF variant) whose tissue was very limited in amount available
due to the small size of a bat brain.
Results
Direct fluorescent antibody test panel testing results
Of the 30 laboratories, from 21 countries, that accepted the invitation to participate in the exer-
cise, 23 laboratories (9 affiliated to MoH and 14 affiliated to MoAg), from 18 countries,
received the panel and completed the proficiency testing exercise. Seven laboratories, two in
Argentina, two in Guatemala, one in Cuba, one in El Salvador and one in Paraguay, did not
receive their samples due to shipping or customs problems. All the participating laboratories
reported their results within two months after receiving the panel.
The agreement between the laboratory results and those of the CDC, as measured by
the sensitivity, specificity, concordance and kappa values are shown in Table 2. Two laborato-
ries correctly identified all samples tested (sensitivity and specificity of 1.0). However, 30%
(7/23) of all laboratories reported at least one false positive and 83% (19/23) of all laboratories
reported at least one false negative sample. The average sensitivity was 76% with a range of
40% to 100%. The average specificity was 88% with a range of 22% to 100%. While a majority
of the laboratories had low false positive rates, there were considerable differences in the sensi-
tivity (Fig 1). The mean concordance was 81% with a range of 50% to 100% and the mean
kappa score was 0.56 with a range of 0.02 to 1.00.
The inter-laboratory agreement by sample is presented in Table 3. The Texas Grey Fox
(S01), the Mongoose/Dog Variant (S02), and the Vampire Bat weak positive control (S19), had
the lowest level of laboratory concordance with, respectively, only 8/23 (30%), 9/23 (39%) and
9/20 (45%, 3 missing) laboratories correctly identifying the sample. Four of the nine negative
samples in the panel had a concordance of less than 0.8, two between 0.8 and 0.9, and only
three negative samples had a high level of concordance (0.91, 0.96 and 1.0).
Logistics and quality control questionnaire
The mean shipping time for laboratories to receive their samples was 11.87 days, ranging from
1 to 65 days (n = 22). Twenty laboratories (87%) reported on the tissue quality of the samples;
two of the 20 reported on the quality of samples 1–18, omitting the control sample quality. The
mean percentage of samples with deficient microscopic condition and impression quality, as
reported by each laboratory, was 13% (range: 0–68%) and 18% (range: 0–63%), respectively.
The three control samples (S18-S20) had the highest proportion of samples reported as Defi-
cient (5/18, 5/18 and 7/18, respectively) when considering impression quality. No statistically
significant correlation was found between shipping time and the percent of tissues with defi-
cient impression (Pearson’s r = 0.06, p-value = 0.77) or microscopic condition (Pearson’s
r = 0.13, p = 0.53, respectively).
Quality control verification
Four months into the exercise and due to perceived problems with the slides reported by
several participating laboratories, we assessed the stability of the rabies antigen and the
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reproducibility of the DFA test results. Duplicate sets of slides were removed from the -80˚C
storage at the CDC and tested for stability under different storage conditions and time. The
complete panel was maintained under 5 different temperatures (-80˚C, -20˚C and 4˚C, room
temperature and 37˚C) as well as 3 different storage times (3, 7 and 14 days) to mimic potential
transport and storage conditions. All combinations of these conditions were run using two dif-
ferent anti-rabies conjugates (FDI Fujirebio Diagnostics Inc. cat# 800–092 and EMD Millipore
Light Diagnostics cat#5100), and one control conjugate EMD Millipore Cat#5102 (non-rabies
FITC labeled antibody of the same isotype as the FITC labelled monoclonal) to assess the spec-
ificity of the reaction. Both the fluorescent intensity and the antigen distribution were reported
for each case. A total of 30 test results (replicas) were reported and analyzed for each of the 20
samples of the panel. The result of this testing was compared against the baseline value pro-
vided by the CDC. There were sufficient sample slides for all planned storage variations except
sample# 12 (WEF variant).
Table 2. Results by Laboratory and agreement relative to CDC expected results.
Laboratory Missing Inconclusive a b c d Sensitivity Specificity Concordance Kappa
L01 0 0 8 0 3 9 0.73 1.00 0.85 0.71
L06 0 0 9 5 2 4 0.82 0.44 0.65 0.27
L07 0 2 9 0 1 8 0.90 1.00 0.94 0.73
L08 0 2 6 0 5 7 0.55 1.00 0.72 0.38
L09 1 0 4 0 6 9 0.40 1.00 0.68 0.39
L10 0 0 10 0 1 9 0.91 1.00 0.95 0.90
L11 0 0 7 0 4 9 0.64 1.00 0.80 0.61
L12 0 1 6 0 4 9 0.60 1.00 0.79 0.54
L13 0 1 11 0 0 8 1.00 1.00 1.00 0.90
L14 0 1 7 0 3 9 0.70 1.00 0.84 0.63
L15 0 0 9 0 2 9 0.82 1.00 0.90 0.80
L16 0 1 8 0 2 9 0.80 1.00 0.89 0.72
L17 2 0 8 2 3 5 0.73 0.71 0.72 0.43
L18 0 0 8 2 3 7 0.73 0.78 0.75 0.50
L20 0 1 11 2 0 6 1.00 0.75 0.89 0.70
L21 3 7 4 2 0 4 1.00 0.67 0.80 0.25
L22 0 1 7 0 3 9 0.70 1.00 0.84 0.63
L23 0 0 5 0 6 9 0.45 1.00 0.70 0.43
L24 0 2 10 0 1 7 0.91 1.00 0.94 0.72
L25 4 0 4 3 5 4 0.44 0.57 0.50 0.02
L27 0 0 11 0 0 9 1.00 1.00 1.00 1.00
L28 0 0 10 7 1 2 0.91 0.22 0.60 0.14
L29 0 2 7 0 3 8 0.70 1.00 0.83 0.55
Missing: Samples with no result due to shipping and/or receiving error–excluded from analysis.
Inconclusive: Samples with inconclusive result as classified by laboratory, unable to determine a positive or negative results. Excluded from the sensitivity





Concordance: percent of laboratory results in agreement the CDC
Kappa: Cohen’s kappa coefficient measures inter-rater agreement considering agreement occurring by chance.
https://doi.org/10.1371/journal.pntd.0005427.t002
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Results indicate that weak positive control (S19) had false negative results at day 3, 7 and 14
at both -80 and 4˚C. Sample 1 also had a negative result after 3 days in storage at -80˚C but was
positive at other times and storage temperatures. Inconsistent results for these two samples
indicate this sample had uneven amount of antigen distributed across the tissue, which is con-
sistent with a low viral load.
Laboratory practices technical questionnaire
The twenty-three participating laboratories answered the practices questionnaire on labora-
tory testing, biosafety and quality control (Tables 4 and 5). All laboratories performed DFA
and had a dedicated rabies laboratory, which was restricted to authorized personnel in 21 labo-
ratories (91%). The laboratories varied in capacity with 52% testing 0–10 samples per week;
one laboratory, affiliated to MoAg reported an average of 120+ samples per week. Only 13
(56%) laboratories responded that the darkroom used for reading DFA slides was for rabies
only. While 22 of 23 laboratories reported having a biological safety cabinet, only 65% are
checked annually and 74% are for rabies only.
While all laboratories reported having a fluorescence microscope, the manufacturer brand
is highly variable. The age of the microscope varied from less than one year (43%) to greater
than 20 years (14%); with 30% of scopes older than 11 years. The light source of the micro-
scope is also highly variable with 82% of the labs using Mercury lamps (HBO 100W or 50W),
while only 13% using LED and 4% using halogen as a light source. For routine scanning of the
DFA slides, 4 laboratories (17%) use a magnifying power of 40X or higher with oil immersion,
Fig 1. Scatterplot of Sensitivity by Specificity. The sensitivity (y-axis), or the true positive rates and the
specificity (x-axis), or the true negative rates, for each laboratory are shown with an open circle. A laboratory
correctly identifying all samples would be found in the upper right corner.
https://doi.org/10.1371/journal.pntd.0005427.g001
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7 laboratories (30%) use a combination of 20X and 40X dry format, and 11 (48%) of the labora-
tories use 40X in a dry format. One laboratory did not know what type of lens was used to scan
the slides. Eighteen (78%) laboratories clean the optical lenses after each use, 21 (91%) have
service records and 16 (70%) have calibration programs.
All laboratories reported having written procedures for sample processing, including trans-
portation, reception, handling, protection storage and safe disposal. However, only 19 (82%)
laboratories had an official DFA protocol and only 4 (17%) had written sample approval and
or rejection criteria.
We found considerable variation in the general laboratory protocols including the area of the
brain used for routine diagnosis, the type of sample used (impressions vs. brain smears), the fixa-
tion protocol (temperature, time and dilutions for slides) and the conjugate procedures (staining
and incubation time). Regarding the selected area of the brain routinely tested, most laboratories
selected from more than one location: 17 laboratories (74%) select the hippocampus, 16 (70%)
the cerebellum, 11 (48%) the cortex and the 11 (48%) brain stem. In addition, a smaller propor-
tion of the labs select the Pons, Thalamus, Spinal cord or olfactory trigone (n = 3, 13%).
The vast majority of laboratories use brain impressions (n = 22, 96%). Only one laboratory
uses brain smears. Nineteen (82%) of the responding laboratories fix the DFA slides. The fixing
solution is also variable with 17 (74%) of laboratories fixing in acetone. Of the18 laboratories
Table 3. Agreement between Laboratory and CDC values, by Sample.
Laboratory Results
Sample Ag Variant CDC I/D Pos Neg Indeter-mined Missing Concordance (%)
S01 Texas Gray Fox 4+/3+ 8 12 3 0 30
S02 Mongoose/ Dog Variant 4+/3+ 9 13 1 0 39
S03 Negative 0/0 3 19 1 0 83
S04 AZ Gray Fox (AV7) 3+/4+ 18 4 1 83
S05 Negative 0/0 4 16 3 0 74
S06 Lasionycteris noctivagans 4+/4+ 19 4 0 87
S07 Tadarida brasiliensis (AV4) 4+/4+ 18 0 0 78
S08 Negative 0/0 4 17 2 0 74
S09 Hognose skunk 4+/4+ 22 1 0 0 96
S10 South Central Skunk US North Central MX 4+/1+ 19 3 1 0 83
S11 Negative 0/0 5 17 1 0 74
S12 Western Eptesicus fuscus 4+/4+ 15 8 0 0 65
S13 Negative 0/0 3 15 3 2 76
S14 Negative 0/0 3 19 0 1 86
S15 Negative 0/0 3 20 0 0 91
S16 Mongoose (PuertoRico) 4+/4+ 20 2 1 0 91
S17 Negative 0/0 1 22 0 0 96
S18 Control 1 LA Dog Variant 4+/4+ 19 2 0 2 95
S19 Control 2 3 (Vampire) 4+/2+ 9 7 4 3 45
S20
Control 3
Negative 0/0 0 21 0 2 100
CDC I/D: CDC determined values for Staining Intensity and Antigen Distribution
Pos: Number of laboratories reporting the sample positive for rabies
Neg: Number of laboratories reporting the sample negative for rabies
Inconclusive: Samples with inconclusive result as classified by laboratory, unable to determine a positive or negative results. Excluded from the sensitivity
and specificity calculations, but included in the kappa and concordance calculations. Concordance: percent of laboratory results in agreement the CDC
https://doi.org/10.1371/journal.pntd.0005427.t003
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that reported on fixing times, 13 (72%) employed between 15 to 60 minutes, 4 (22%) from 1 to
4 hrs, and 1 left the slides overnight. Of the 20 laboratories that reported on fixation tempera-
tures, 16 (69%) reported temperatures of -20˚C, and the remaining three reported tempera-
tures of 80˚C, 4˚C, and room temperature, respectively.
The conjugate is a critical reagent in DFA; 20 (87%) laboratories use a single conjugate for
rabies diagnosis, while 3 laboratories use more than one. Sixty-five percent of responders
Table 4. Selected questions of the rabies laboratory practices questionnaire and results.
Survey Item and Response Freq. Percent Sensitivity(Mean) Test Stat p-value
Number of rabies samples tested per week - 0.07 0.93
0–10 12 52 0.78 - -
11–30 5 22 0.78 - -
>30 6 26 0.75 - -
Number of people performing tests in the lab - 2.5 0.11
1–2 8 35 0.86 - -
3–4 11 48 0.69 - -
4+ 4 17 0.81 - -
Has a formal quality program - 44.5 0.82
Yes 17 74 0.78 - -
No 6 26 0.74 - -
Has a quality control person with direct access to top level management - 35.5 1.00
Yes 19 83 0.78 - -
No 4 17 0.75 - -
Has established, written lab quality manual - 24.5 0.65
Yes 21 91 0.76 - -
No 2 9 0.85 - -
Rabies lab is restricted to the (rabies) testing personnel - 26.0 0.53
Yes 21 91 0.76 - -
No 2 9 0.86 - -
Biological safety cabinet systems annually verified - 48.5 1.00
Yes 15 65 0.78 - -
No 7 30 0.76 - -
Missing 1 4
Biological safety cabinet restricted for rabies testing - 25.5 0.24
Yes 17 74 0.80 - -
No 5 22 0.68 - -
Missing 1 4
Has a fluorescence microscope - - -
Yes 23 100 - - -
No 0 0 - - -
Age of scope (years) - 1.63 0.22
0–5 10 44 0.80 - -
6–15 8 35 0.68 - -
>15 5 22 0.85 - -
Optical surfaces cleaned after every use - 44.5 0.49
Yes 18 78 0.76 - -
No 5 22 0.84 - -
https://doi.org/10.1371/journal.pntd.0005427.t004
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using a commercial source and 35% using a conjugated produced by a regional, national or
local rabies laboratory. Eighteen (78%) laboratories do not use a rabies negative control FITC
labeled conjugate. Eighteen (78%) laboratories incubate the stained slides for 30 min while 5
laboratories incubate the slides for 15, 20, 40, 45 and 60 minutes, respectively.
Table 5. Selected questions of the rabies laboratory practices questionnaire and results.
Survey Item and Response Freq. Percent Sensitivity(Mean) Test Stat p-value
Service and maintenance records available - 8.0 0.19
Yes 21 91 0.79 - -
No 2 9 0.56 - -
Has calibration programs for the laboratory instruments - 51.0 0.94
Yes 16 70 0.78 - -
No 7 30 0.76 - -
Has an official (institutional) DFA protocol - 58.5 0.06
Yes 19 83 0.74 - -
No 4 17 0.92 - -
Approval and/or rejection criteria of samples established and written - 25.5 0.39
Yes 4 17 0.85 - -
No 19 83 0.76 - -
# of people who read slides per test - 71.5 0.49
1 11 48 0.75 - -
2–3 12 52 0.79 - -
Performs confirmatory test(s) on weak or inconclusive samples - 46.5 0.09
Yes 20 87 0.74 - -
No 3 13 0.91 - -
Participates in a proficiency program for rabies - 54.0 0.94
Yes 8 35 0.78 - -
No 15 65 0.77 - -
Routinely checks VNA titer of all rabies lab employees - 54.5 0.95
Yes 15 65 0.78 - -
No 8 35 0.76 - -
Area of brain used for samples (labs may report >1 area) - - -
Hippocampus 17 74 - - -
Cerebellum 16 70 - - -
Cortex 11 48 - - -
Brain Stem (medulla oblongata) 11 48 - - -
Pons 2 9 - - -
Thalamus 1 4 - - -
Spinal cord 1 4 - - -
Olfactory Trigone 1 4 - - -
# of Anti-Rabies Conjugates Used - 5.0 0.11
1 20 87 0.75 - -
2 3 13 0.96 - -
Uses rabies negative control FITC labeled Conjugate - 52.5 0.45
Yes 5 22 0.72 - -
No 18 78 0.79 - -
Slide Incubation Time (Minutes) - 20.5 0.47
30 or less 20 87 0.76 - -
>30 3 13 0.84 - -
https://doi.org/10.1371/journal.pntd.0005427.t005
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One laboratory incubates the stained slides at room temperature while the rest of laborato-
ries (22, 95%) incubate at 37˚C. Differences were also seen in the solutions used for washing the
slides, the time and washing steps and the mounting media used to coverslip: 17% of the labora-
tories use 2x 3–5 min PBS rinses and 13% use as mounting media 90% glycerol in carbonate-
bicarbonate buffer pH 9.0. Eleven (48%) laboratories use only one dedicated slide reader, 10
(43%) use 2 and 2 laboratories have 3 readers per slide. Although 20 (86%) laboratories perform
a confirmatory testing on weak or inconclusive results, 3 (13%) do not have this capacity. The
most common confirmatory test reported was the mouse inoculation (n = 15, 65%) followed by
repeat DFA with using an un-labelled monoclonal to assess the specificity of the fluorescence
(n = 4, 17%). Only one laboratory uses cell culture and two laboratories (9%) use RT-PCR.
Sixty-five percent of the laboratories [15] reported having at least three dedicated laboratory
employees for rabies diagnostics. While all the laboratories require pre-exposure prophylaxis
for their employees, 5 (22%) check the employee titer biannually, 7 (30%) annually, 3 (9%)
biennially and 9 (39%) reported that they don’t check or did not have a specific time frame for
checking employee titers.
Only 8 laboratories (35%) reported participating in a proficiency testing program for rabies,
different from this one, 17 (74%) had a formal quality control program, and 19 (82.6%) had a
person responsible for quality control with access to top level management.
Discussion
The level of concordance between the 23 participating laboratories and the CDC panel showed
large variability. Two laboratories had 100% concordance, while 91% of the labs had at least one
discordant sample, with a total of 26 false positive and 61 false negative results among all laborato-
ries. This level of concordance is lower than those found in similar inter-laboratory exercises of
DFA diagnosis of rabies elsewhere. In an inter-laboratory exercise of Middle and Eastern Euro-
pean countries in 2001 [11], 3 of the 16 (19%) participating national laboratories produced false-
positive results. During the EURL/ANSES annual inter-laboratory trials from 2009 to 2014, which
included 5 laboratories from the Americas, the percent of laboratories with at least one discordant
sample ranged from 8% to 20% [15]. One possible cause of the lower level of concordance relative
to other studies, may be related to the sample stability during shipping and conditions of storage
of the panel. However, we did not find a significant association between the shipping time and the
laboratory-reported microscopic and tissue impression quality. This assumes that shipping time
captures adequately unobserved variables such as shipping and storage temperature. At the times
and temperatures of shipping and/or storage evaluated in this study, the CDC found no impact
on the degree of positivity of samples, with the exception of the weak positive control. Only 4 pan-
els had shipping times longer than the 14 day limit of the stability test (2 labs with 15 and 16 days,
respectively). In addition, we tested the level of concordance for the subset of PT panels delivered
within the 14-day limit of the stability test, which encompasses 81% of all the panels tested across
LAC, and found no significant increase in the concordance among laboratories.
For the current exercise, a technical questionnaire was completed in parallel to the panel
in order to identify variations in methodology, equipment and human resources that could
potentially explain discordant results to help implement standardized rabies diagnosis proto-
cols across the region. While no significant associations were seen between differences in
survey responses and laboratory performance, this may be due to the small sample size, as
even small methodological changes have been shown to affect the sensitivity of the DFA test
including the mounting medium [16–17], laboratorian’s expertise level, number of employees
reading the slides, the anti-rabies conjugate utilized, specificity controls used and working per-
formance of fluorescence microscope [18, 19].
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Forty-percent of the laboratories have only one person reading the slides. While no differ-
ence in sensitivity was found between laboratories with one or two readers, the OIE manual
for DFA recommends two readers per slide [3] and in the EURL/ANSES study, laboratories
using two readers had a higher concordance during the DFA than laboratories with one reader
[18].
Half of the participating laboratories tested less than 10 samples per week. While the sensi-
tivity did not vary by laboratory work load in this study, laboratories with small throughput
may have reduced test interpretation expertise. In the Barrat 2001 inter-laboratory technical
questionnaire, low laboratory throughput was generally associated with a lower frequency in
the use of fresh (recently prepared, replaced for new one from the bottle or reagents far from
expiring) reagents including fixatives, buffers and solutions, which in turn will affect the ana-
lytical sensitivity and quality of the test [14].
The type of conjugate may also affect the sensitivity of the DFA test (monoclonal cocktail
versus polyclonal, in-house made versus commercial). For the current exercise, laboratories
used commercial (65%) or in-house (35%) conjugates. A study of 12 rabies reference laborato-
ries in Europe demonstrated that the variability of conjugates could potentially lead to discor-
dant results and influence assay sensitivity [19]. The OIE manual states that the conjugates
should be fully validated for specificity and sensitivity before use, including their ability to
detect lyssaviruses other than rabies [3]; it is unclear whether such validation has been com-
pleted for the in-house conjugates used in the LAC region. It was recommended by members
of the regional laboratory network during a briefing on the results of this exercise that PAHO
should provide a standard set of conjugates for future exercises to reduce the potential variabil-
ity in results associated with conjugate type.
The maintenance, type and quality of fluorescence microscope including quality and type
optical lens, magnification and numerical aperture could also affect the DFA results. All labs
reported having a fluorescence microscope. However, the manufacturer brand, age, light
source and magnifying power was highly variable, which may have affected the overall concor-
dance results among laboratories.
The PT panel was composed of 20 samples with samples of diverse origin. Potentially, the
variety of samples and virus variants caused difficulty for some laboratories. The Texas Grey
Fox (S01), the Mongoose/Dog Variant (S02), and the Vampire Bat weak positive control (S19)
had the lowest level of laboratory concordance. In a two-year review of the 2009–2010 EURL/
ANSES international inter-laboratory trials all errors were associated with bat strains (EBLV-
1, EBLV-2 and ABLV); the authors commented that these strains do not provide the same type
of fluorescence than the conventional RABV strains, which could lead to false negative results
[20].
Among the participating laboratories, 28% did not have a written DFA protocol and 82%
did not have a written sample approval or rejection criteria. There was variation in the general
protocol for sample selection and processing, including the area of brain routinely tested, the
type of sample (impressions vs. brain smears), and the fixation protocol, including tempera-
ture, time and dilutions for the slides. Details in execution of the immune-staining procedure,
including incubation times, incubation temperatures, number of washes as well as mounting
medium used also varied greatly. Variations in slide preparation and in the DFA protocols
were noted in the 2001 WHO inter-laboratory study [14], particularly in the use of heat and/or
acetone for fixation and fixation time and temperature. Variation in methodology including
rinsing and washing times, fixation procedures, type of conjugate used and the staining time
and temperature was also noted in the 2009–2010 EURL/ANSES technical questionnaires;
nevertheless, in this study, the number of persons reading the same slide was the only factor
that significantly affected the proficiency test results [18]. Standardized protocols for DFA
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exist from the OIE Terrestrial Manual, the CDC, the EURL and the WHO [12, 21, 3]. The
LAC region would benefit from the use of standardized DFA protocols.
Three of the 23 laboratories did not have the capacity to perform a confirmatory testing on
weak or inconclusive results. The most common confirmatory test reported was the mouse
inoculation; only two laboratories use RT-PCR. Although, the WHO does not currently rec-
ommend RT-PCR as a primary rabies routine diagnostic tool, a number of laboratories in
LAC are in the process of implementing RT-PCR as a confirmatory test as ascertained during
the post-exercise briefing. In an European ring test study, RT-PCR showed a high level of vari-
ation between laboratories with cross-contamination as a potential issue [4]. Concerns about
the potential of RT-PCR to identify imported strains were raised by Fischer et al., 2013. Given
the expressed interest of LAC laboratories to implement RT-PCR, a region-wide RT-PCR
harmonization exercise is recommended due to the test’s requirements for strict quality con-
trol protocols and high level of experience and expertise for accurate diagnosis [2].
In contrast to the acetone-fixed slides provided in this exercise, the three inter-laboratory
studies cited in this discussion used freeze-dried viable virus homogenates obtained from ani-
mals inoculated intra-cerebrally [14, 15, 20]. The use of fully inactivated gamma radiated
homogenates in future iterations of this exercise would also allow for each lab to test its slide
or smear preparation protocol as commented in Barrat et al.,2007. Furthermore, homogeniz-
ing the material in their own laboratory settings may provide more consistency across the pan-
els than impressions from an infected brain [14].
The WHO recommends the preventive immunization of all staff handling infected or
suspect material with the titer checked every 6 months. While all of the laboratories participat-
ing in this exercise required pre-exposure prophylaxis for employees, only 21.7% of the labs
reported that employee titers are checked in compliance of WHO-recommendations. Em-
ployee safety should be a primary concern for all rabies laboratories and a regional effort to
increase the frequency of employee titer checks should be implemented.
As a first iteration of a regional DFA inter-laboratory exercise, this effort provided useful
insights into the lab performance and protocols, as well as suggested improvements for future
rounds of the exercise. There is a clear need to increase participation in regional exercises on
rabies diagnosis across LAC, since only 34.8% of the 23 laboratories reported previous partici-
pation in diagnostic test exercises of this nature. A regional laboratory network (REDILAR) is
part of the REDIPRA plan for elimination of canine-rabies in the Americas [6]. Noting the het-
erogeneity in the DFA protocols described in the technical surveys conducted in this study,
and the level of discordant results, an effective REDILAR network is critical to develop a rabies
diagnosis and reporting harmonization scheme concerted with an annual testing exercise in
the way it has been implemented for Europe [21, 22].
Results of this exercise were presented before the Regional Meeting of the Rabies Directors
of the Americas in 2015 (REDIPRA 15), which end up in an official resolution instructing the
REDILAR coordinated by PANAFTOSA, to define a framework for the harmonization of
rabies diagnosis and to implement annual exercises. This resolution demonstrates the commit-
ment by the national authorities, PAHO, and WHO Collaborating Centers for Rabies Research
to support the REDILAR laboratory network in improving the sensitivity of rabies diagnosis.
Sensitivity, specificity as well as timely rabies diagnosis and surveillance will be of increasing
relevance in the race towards elimination of human rabies transmitted by dogs in the Region.
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